Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications

Journal of Hypertension

Volumn 28, Issue 9, 2010, Pages 1944-1950

  Fortuño, Ana ^a   Bidegain, Julen ^a   Baltanás, Ana ^a   Moreno, María U ^a   Montero, Laura ^b   Landecho, Manuel F ^b   Beloqui, Oscar ^b   Díez, Javier ^a,c   Zalba, Guillermo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

leptin; NADPH oxidase; obesity; vascular remodeling

Indexed keywords

BISINDOLYLMALEIMIDE; LEPTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; WORTMANNIN;

ADULT; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ATHEROSCLEROSIS; BLOOD CHEMISTRY; BLOOD SAMPLING; BLOOD VESSEL WALL; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HYPERLEPTINEMIA; LUMINESCENCE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 77955850314     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833c21af     Document Type: Article

References (32)

1. Eckel RH, York DA, Rossner S, Hubbard V, Caterson I, St Jeor ST, et al. Prevention Conference VII: obesity, a worldwide epidemic related to heart disease andstroke: executive summary. Circulation2004; 110:2968-2975.
2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006; 26:968-976.
3. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007; 27:996-1003.
4. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001; 86:355-362.
5. Patel C, Ghanim H, Ravishankar S, Sia CL, Viswanathan P, Mohanty P, Dandona P. Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese. J Clin Endocrinol Metab 2007; 92:4476-4479.
6. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23:434-439.
7. Bokoch GM, Knaus UG. NADPH oxidases: not just for leukocytes anymore!. Trends Biochem Sci 2003; 28:502-508.
8. BedardK,Krause KH. TheNOX familyofROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87:245-313.
9. Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, et al. Cytochrome b558-dependent NAD(P)H oxidase-phox unitsinsmooth muscle and macrophages of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2002; 22:2037-2043.
10. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002; 105:1429-1435.
11. Zalba G, Fortuño A, Orbe J, San José G, Moreno MU, Belzunce M, et al. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: implications for human atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27:587-593.
12. Zalba G, Beloqui O, San José G, Moreno MU, Fortuño A, D́ez J. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol 2005; 25:1452-1457.
13. Mancini GB, Dahlof B, D́ez J. Surrogate markers for cardiovascular disease: structural markers. Circulation 2004; 109:IV22-II30.
14. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res 2005; 126:121-129.
15. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189:47-60.
16. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008; 52:1201-1210.
17. Patel JV, Lim HS, Dubb K, Hughes EA, Lip GY. Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension. Ann Med 2009; 41:291-300.
18. Galletti F, D'Elia L, Barba G, Siani A, Cappuccio FP, Farinaro E, et al. High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study. J Clin Endocrinol Metab 2008; 93:3922-3926.
19. Beltowski J, Wojcicka G, Marciniak A, Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 2004; 74:2987-3000.
20. Dong F, Zhang X, Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 2006; 47:222-229.
21. Li L, Mamputu JC, Wiernsperger N, Renier G. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes 2005; 54:2227-2234.
22. Fortuño A, Bidegain J, San José G, Robador PA, Landecho MF, Beloqui O, et al. Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients. J Hypertens 2009; 27:1420-1430.
23. Fortuño A,San José G, Moreno MU, Beloqui O, D́ezJ,Zalba G.Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 2006; 55:209-215.
24. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111:1448-1454.
25. Silver AE, Beske SD, Christou DD, Donato AJ, Moreau KL, Eskurza I, et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 2007; 115:627-637.
26. Erdös B, Snipes JA, Tulbert CD, Katakam P, Miller AW, Busija DW. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am J Physiol Heart Circ Physiol 2006; 290:H1264-H1270.
27. Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:23-28.
28. Dorffel Y,Franz S,Pruss A,NeumannG, Rohde W, Burmester GR, Scholze J. Preactivated monocytes from hypertensive patients as a factor for atherosclerosis? Atherosclerosis 2001; 157:151-160.
29. Fortuño A, Oliván S, Beloqui O, San José G, Moreno MU, D́?ez J, Zalba G. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 2004; 22:2169-2175.
30. Ciccone M, Vettor R, Pannacciulli N, Minenna A, Bellacicco M, Rizzon P, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001; 25:805-810.
31. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25:29-38.
32. Myara I, Alamowitch C, Michel O, Heudes D, Bariety J, Guy-Grand B, Chevalier J. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 2003; 11:112-120.